(Q58867371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

J Alexander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Jennings

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S A Mohamedi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A W Heath

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

2083-2094

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

Subclinical herpes virus reactivation and latency.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Neonatal herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Encephalitis. Identifying the specific cause is key to effective management

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Infections due to the herpesvirus group in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Challenges and progress in developing herpesvirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization aga

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Particulate Aspergillus fumigatus antigens elicit a TH2 response in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Humoral and cell-mediated immunity in neonates with herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: comparison of in vivo effects of IL-2 and IL-7 on adoptively transferred T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Herpes simplex virus-specific cytolytic T lymphocytes restricted to a normally low responder H-2 allele are protective in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Characterization of T cell responses to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISpot cytokine assay

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Protection against Zosteriform Spread of Herpes Simplex Virus by Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

The demonstration of an essential role for macrophages in the in vivo generation of IgG2a antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a multi-glycoprotein structure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Comparative studies of HSV-1 antigens solubilised from infected cells by using non-ionic or zwitterionic detergents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

The host response to herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Topological distribution of virus-specific and cross-reactive antigenic determinants on the gB glycoprotein of the herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Zwitterionic detergent solubilisation of HSV-1 surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

IgG2a restriction of murine antibodies elicited by viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Virally induced modulation of murine IgG antibody subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Enhancement of IgG anti-carrier responses by IgG2 anti-hapten antibodies in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Cytotoxicity mediated by human Fc receptors for IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Iscoms Containing PurifiedQuillajaSaponins Upregulate both Th1-like and Th2-like Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900567-8

7 January 2021

10.1016/S0264-410X(99)00567-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10715522%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference